Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?

    ... Iron overload (IOL) portends inferior outcome in myelodysplastic ... had ferritin levels available, and were not receiving iron chelation therapy. Baseline characteristics were not significantly different ...

    Research Article last updated 12/09/2015 - 8:52am.

  2. Iron Chelation

    ... Red blood cells contain iron. Each time you get a red blood cell transfusion you are putting ... iron overload? Iron chelation therapy is used when you have a condition called iron ...

    Topic section last updated 06/23/2016 - 3:56pm.

  3. Iron overload in myelodysplastic syndromes: diagnosis and management.

    ... symptomatic management of refractory anemia . Iron overload ensues when the iron acquired from transfused RBCs exceeds body ... surveys, and phase II studies indicate that iron chelation therapy reduces iron load as measured by changes in serum ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry

    ... 600 lower-risk MDS patients (pts) with transfusional iron overload . Clinical outcomes were compared between chelated and ... MDS therapy was more common in chelated pts. At 24 months, chelation was associated with longer median overall survival (52.2 months vs. ...

    Research Article last updated 01/08/2014 - 9:35am.

  5. Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy

    ... patients with MDS receiving deferasirox therapy remains stable over time. HRQOL assessment might also provide ...

    Research Article last updated 09/24/2014 - 10:50am.

  6. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management

    ... may include the use of prophylactic antibiotics and iron chelation. Management of progressive or refractory disease: There are ...

    Research Article last updated 02/04/2014 - 1:37pm.

  7. Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management

    ... may include the use of prophylactic antibiotics and iron chelation. Management of progressive or refractory disease: At the ...

    Research Article last updated 07/31/2012 - 2:02pm.

  8. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management

    ... may include the use of prophylactic antibiotics and iron chelation. MANAGEMENT OF PROGRESSIVE OR REFRACTORY DISEASE: At the ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. Iron Chelation Therapy

    Iron overload occurs when you have too much iron in your body. This can be ... Iron overload can be treated with phlebotomy or with chelation therapy. Phlebotomy: Phlebotomy is the process of taking blood out of ...

    Page last updated 01/20/2015 - 4:40pm.

  10. Iron Overload and MDS

    ... PubMed Abstract:  Iron overload and chelation therapy in myelodysplastic syndromes ...

    Research Review last updated 05/02/2016 - 9:18am.